IM Cannabis (IMCC) Income from Discontinued Operations (2021 - 2026)
IM Cannabis (IMCC) posted quarterly Income from Discontinued Operations of 29897.43 for Q1 2026, up 47.93% year-over-year from 20210.58 in Q1 2025, and up 47.93% quarter-over-quarter from 20210.58 in Q1 2025.
IM Cannabis (IMCC) Income from Discontinued Operations (2021 - 2026) Analysis & Trends
IM Cannabis' Income from Discontinued Operations history runs 6 years deep, the most recent figure standing at 29897.43 for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | IM Cannabis | 554,496.00 | -614,474.17 | 1.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29,897.43 |
| Mar 31, 2025 | 20,210.58 |
| Jun 30, 2024 | -613,426.92 |
| Mar 31, 2024 | 82,374.57 |
| Jun 30, 2023 | -119,112.39 |
| Mar 31, 2023 | -11,835.14 |
| Sep 30, 2022 | -93,543.04 |
| Jun 30, 2022 | -789,831.04 |
| Mar 31, 2022 | -177,631.97 |
| Sep 30, 2021 | -24,626.69 |